These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4435008)

  • 21. Pharmacology of orally administered 9 -tetrahydrocannabinol.
    Perez-Reyes M; Lipton MA; Timmons MC; Wall ME; Brine DR; Davis KH
    Clin Pharmacol Ther; 1973; 14(1):48-55. PubMed ID: 4683071
    [No Abstract]   [Full Text] [Related]  

  • 22. Contribution of the metabolite 7-hydroxy-delta1-tetrahydrocannabinol towards the pharmacological activity of delta 1-tetrahydrocannabinol in mice.
    Gill EW; Jones G; Lawrence DK
    Biochem Pharmacol; 1973 Jan; 22(2):175-84. PubMed ID: 4763251
    [No Abstract]   [Full Text] [Related]  

  • 23. Determinants of the disposition of 14C-delta 9-tetrahydrocannabinol and 3H-delta 9-tetrahydrocannabinol.
    Siemens AJ; Doyle OL; Pryor GT
    Life Sci; 1979 Apr; 24(14):1261-74. PubMed ID: 470542
    [No Abstract]   [Full Text] [Related]  

  • 24. 9 -Tetrahydrocannabinol and its metabolites in monkey brains.
    Ho BT; Estevez V; Englert LF; McIsaac WM
    J Pharm Pharmacol; 1972 May; 24(5):414-6. PubMed ID: 4403817
    [No Abstract]   [Full Text] [Related]  

  • 25. Excretion of trans- 9 -tetrahydrocannabinol and its metabolites in intact and bile duct-cannulated rats.
    Turk RF; Dewey WL; Harris LS
    J Pharm Sci; 1973 May; 62(5):737-40. PubMed ID: 4705677
    [No Abstract]   [Full Text] [Related]  

  • 26. The distribution and excretion of tetrahydrocannabinol-C 14 in humans.
    Miras C; Coutselinis A
    Med Sci Law; 1971 Oct; 11(4):197-9. PubMed ID: 5148725
    [No Abstract]   [Full Text] [Related]  

  • 27. Delta-9-tetrahydrocannabinol: localization in body fat.
    Kreuz DS; Axelrod J
    Science; 1973 Jan; 179(4071):391-3. PubMed ID: 4682965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of delta-1-tetrahydrocannabinol by the rat in vivo and in vitro.
    Siemens AJ; Kalant H
    Biochem Pharmacol; 1975 Apr; 24(7):755-62. PubMed ID: 235932
    [No Abstract]   [Full Text] [Related]  

  • 29. Brain levels of delta1-tetrahydrocannabinol and its metabolites in mice tolerant to the hypothermic effect of delta1-tetrahydrocannabinol.
    Lawrence DK; Pertwee RG
    Br J Pharmacol; 1973 Oct; 49(2):373-5. PubMed ID: 4793443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (2-14C) amobarbital metabolism in tolerant rats.
    Misra AL; Pontani RB; Mulé SJ
    Xenobiotica; 1974 Jul; 4(7):409-23. PubMed ID: 4432532
    [No Abstract]   [Full Text] [Related]  

  • 31. Binding of (+)- and (minus)-delta-1-tetrahydrocannabinols and (minus)-7-hydroxy-delta-1-tetrahydrocannabinol to blood cells and plasma proteins in man.
    Widman M; Agurell S; Ehrnebo M; Jones G
    J Pharm Pharmacol; 1974 Nov; 26(11):914-6. PubMed ID: 4156569
    [No Abstract]   [Full Text] [Related]  

  • 32. Distribution of delta 9-tetrahydrocannabinol in the mouse.
    Freudenthal RI; Martin J; Wall ME
    Br J Pharmacol; 1972 Feb; 44(2):244-9. PubMed ID: 4668591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking.
    Ohlsson A; Lindgren JE; Wahlen A; Agurell S; Hollister LE; Gillespie HK
    Clin Pharmacol Ther; 1980 Sep; 28(3):409-16. PubMed ID: 6250760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma protein binding of 7-hydroxy- 1-tetrahydrocannabinol: an active 1-tetrahydrocannabinol metabolite.
    Widman M; Nilsson IM; Agurell S; Borg H; Granstrand B
    J Pharm Pharmacol; 1973 Jun; 25(6):453-7. PubMed ID: 4146583
    [No Abstract]   [Full Text] [Related]  

  • 35. Metabolism and autoradiographic distribution of delta-8- and delta-9-tetrahydrocannabinol in some organs of the monkey Callithrix jacchus.
    Just WW; Erdmann G; Thel S; Werner G; Wiechmann M
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287(2):219-25. PubMed ID: 806815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
    Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
    Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 6 -hydroxy- 1 -tetrahydrocannabinol synthesis and biological activity.
    Ben-Zvi Z; Mechoulam R; Edery H; Porath G
    Science; 1971 Nov; 174(4012):951-2. PubMed ID: 5001309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.
    Huestis MA; Cone EJ
    J Anal Toxicol; 2004 Sep; 28(6):394-9. PubMed ID: 15516285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human urinary excretion profile after smoking and oral administration of [14C]delta 1-tetrahydrocannabinol.
    Johansson E; Gillespie HK; Halldin MM
    J Anal Toxicol; 1990; 14(3):176-80. PubMed ID: 2165199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism and disposition of delta-9-tetrahydrocannabinol in man.
    Lemberger L; Axelrod J; Kopin IJ
    Pharmacol Rev; 1971 Dec; 23(4):371-80. PubMed ID: 4943951
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.